High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
about
Seasonal inactivated influenza virus vaccinesSafety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adultsImmunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies.Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults.Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults.Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjectsAntibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.Quantitative review of antibody response to inactivated seasonal influenza vaccines.Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccineA dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adultsFluBlok, a recombinant hemagglutinin influenza vaccine.Production of a novel influenza vaccine using insect cells: protection against drifted strainsA 2013/2014 northern hemisphere season surface antigen inactivated trivalent influenza vaccine--Assessing the immunogenicity and safety in an open label, uncontrolled study.Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.Rituximab-treated patients have a poor response to influenza vaccinationEfficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid/DNA adjuvant.Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
P2860
Q24652665-90CFFD64-2534-475D-ADF6-766727271ABCQ26781949-00093351-E7C4-4651-B6CB-E090B0365132Q30355688-5B1B157D-CBA3-4008-8996-98D65903C759Q30362618-2546FFE5-173C-403D-8C06-8F5D80BFDA6FQ30372195-977D0396-C702-4971-B63E-3528BBDECF35Q30378572-9EE513A6-E640-4DB9-9D98-2A3746C4185FQ30409342-03C2D6F6-47FE-4B66-8753-0967AE2F5816Q30417077-1C1E3397-C641-496A-9B52-8895710A6288Q30425783-C625BFBE-9160-4E3A-844A-E4FA0880B723Q34697810-A1BAE4F9-42EA-418D-8DCD-998DC94BD12CQ34761957-F791DF30-45A9-4E89-9DBD-034BB6D4F708Q35218808-D3E4A58C-99AA-422C-B8FF-3D019A047265Q35227637-A45BFEAE-2873-46F7-B50C-E3A9ABDBF9DBQ35866636-1BB248DA-E87A-40B7-8735-F71E271B7E97Q36116560-EC9ECBBB-43AA-48D7-97ED-B506099492C4Q36251189-74623C6E-FF01-41E0-8A4D-596C68DC51D1Q36252802-A647A40F-96FE-40D3-BF8C-EFB066F99A67Q36256268-88B7E29A-6588-49B1-AF9F-4208F952ED85Q36462309-23542B0C-DF7D-48CC-9D19-0FC6B314EE94Q36589247-6A4296BE-C583-4B32-8AA0-BAF0EE413DCDQ37395334-69F0DCB1-25C6-42D6-9C01-3D456CF95EB6Q37423256-61BACF9E-6DD6-442A-8B2D-E69D1F3BA790
P2860
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1994
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High doses of purified influen ...... onses in healthy young adults.
@en
High doses of purified influen ...... onses in healthy young adults.
@nl
type
label
High doses of purified influen ...... onses in healthy young adults.
@en
High doses of purified influen ...... onses in healthy young adults.
@nl
prefLabel
High doses of purified influen ...... onses in healthy young adults.
@en
High doses of purified influen ...... onses in healthy young adults.
@nl
P2093
P2860
P1476
High doses of purified influen ...... onses in healthy young adults.
@en
P2093
J M Quarles
W A Keitel
P2860
P304
P407
P577
1994-10-01T00:00:00Z